Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain-Reference-Cited by-同舟云学术

Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain

Published:2020-04 Issue: Volume:1 Page:19-29
ISSN:2590-2571
Container-title:Current Research in Pharmacology and Drug Discovery
language:en
Short-container-title:Current Research in Pharmacology and Drug Discovery

Author:

Wahlberg Lars U.,Emerich Dwaine F.,Kordower Jeffrey H.,Bell William,Fradet Tracie,Paolone Giovanna^ORCID

Funder

Michael J. Fox Foundation for Parkinson's Research

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model;Dowd;Eur. J. Neurosci.,2005

2. Widespread striatal delivery of GDNF from encapsulated cells prevents the anatomical and functional consequences of excitotoxicity;Emerich;Neural. Plast.,2019

3. Encapsulated cell therapy for neurodegenerative diseases: From promise to product;Emerich;Adv. Drug Deliv. Rev.,2014

4. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts;Emerich;Brain. Res.,1996

5. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of alzheimer's disease patients: Application of a second-generation encapsulated cell biodelivery device;Eyjolfsdottir;Alzheimers Res. Ther.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to AppNL−G−F knock-in Alzheimer mice;Alzheimer's Research & Therapy;2023-08-18

2. Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology;Molecular Therapy - Methods & Clinical Development;2022-09

3. Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease;Molecular and Cellular Neuroscience;2022-01

4. Where Dopaminergic and Cholinergic Systems Interact: A Gateway for Tuning Neurodegenerative Disorders;Frontiers in Behavioral Neuroscience;2021-07-22

5. Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson’s Disease;Neural Plasticity;2020-11-26